Molecular Imaging and Oral Cancer Diagnosis and Therapy

Journal of Cellular Biochemistry

Volumn 118, Issue 10, 2017, Pages 3055-3060

  Keshavarzi, Maryam ^a   Darijani, Mansoreh ^b   Momeni, Fatemeh ^c   Moradi, Pouya ^d   Ebrahimnejad, Hamed ^b   Masoudifar, Aria ^e   Mirzaei, Hamed ^f  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DIAGNOSIS; IMAGING TECHNIQUE; ORAL CANCER; THERAPY

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ARTICLE; CANCER STAGING; CANCER THERAPY; EARLY CANCER DIAGNOSIS; HUMAN; MOLECULAR IMAGING; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ANIMAL; DIAGNOSTIC IMAGING; METABOLISM; MOUTH TUMOR; PROCEDURES; SQUAMOUS CELL CARCINOMA;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; HUMANS; MOLECULAR IMAGING; MOUTH NEOPLASMS;

EID: 85026916358     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.26042     Document Type: Article

References (94)

1. Balan JJ, Rao RS, Premalatha B, Patil S. 2012. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: A comparative study. J Contemp Dent Pract 13(5):671–675.
2. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, Nesic VS, Markovic SZ, Martinovic ZR, Akin D. 2011. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol 47(1):51–55.
3. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang W-W, Kim MM. 2011. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res 17(14):4782–4789.
4. Chang C-C, Yang Y-J, Li Y-J, Chen S-T, Lin B-R, Wu T-S, Lin S-K, Kuo MY-P, Tan C-T. 2013. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol 49(9):923–931.
5. Chauhan A, Kulshrestha P, Kapoor S, Singh H, Jacob M, Patel M, Ganguly M. 2012. Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma. Med J Armed Forces India 68(4):322–327.
6. Chen YC, Li TY, Tsai MF. 2002. Analysis of the saliva from patients with oral cancer by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 16(5):364–369.
7. Cheng Y-SL, Rees T, Wright J. 2014. A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med 3(1):1.
8. Contucci A, Inzitari R, Agostino S, Vitali A, Fiorita A, Cabras T, Scarano E, Messana I. 2005. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: A preliminary report. Oral Dis 11(2):95–99.
9. Dammann F, Horger M, Mueller-Berg M, Schlemmer H, Claussen C, Hoffman J, Eschmann S, Bares R. 2005. Rational diagnosis of squamous cell carcinoma of the head and neck region: Comparative evaluation of CT, MRI, and 18FDG PET. Am J Roentgenol 184(4):1326–1331.
10. de Bree R, Castelijns JA, Hoekstra OS, Leemans CR. 2009. Advances in imaging in the work-up of head and neck cancer patients. Oral Oncol 45(11):930–935.
11. El-Hafez YGA, Chen C-C, Ng S-H, Lin C-Y, Wang H-M, Chan S-C, Chen I-H, Huan S-F, Kang C-J, Lee L-Y. 2011. Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 47(4):288–295.
12. Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A. 2012. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prevent 21(4):664–672.
13. Fathullahzadeh S, Mirzaei H, Honardoost M, Sahebkar A, Salehi M. 2016. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. Cancer Gene Ther 23(10):327–332.
14. Gholamin S, Pasdar A, Sadegh Khorrami M, Mirzaei H, Reza Mirzaei H, Salehi R, Ferns GA, Ghayour-Mobarhan M, Avan A. 2016. The potential for circulating microRNAs in the diagnosis of myocardial infarction: A novel approach to disease diagnosis and treatment. Curr Pharm Des 22(3):397–403.
15. Gu DH, Yoon DY, Park CH, Chang SK, Lim KJ, Seo YL, Yun EJ, Choi CS, Bae SH. 2010. CT, MR, 18F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity. Acta Radiol 51(10):1111–1119.
16. Hakim SG, Wieker H, Trenkle T, Sieg P, Konitzer J, Holl-Ulrich K, Jacobsen H-C. 2014. Imaging of mandible invasion by oral squamous cell carcinoma using computed tomography, cone-beam computed tomography and bone scintigraphy with SPECT. Clin Oral Investig 18(3):961–967.
17. Handschel J, Naujoks C, Depprich RA, Kübler NR, Kröpil P, Kuhlemann J, Jansen TM, Boeck I, Sproll KC. 2012. CT-scan is a valuable tool to detect mandibular involvement in oral cancer patients. Oral Oncol 48(4):361–366.
18. Hendrikx A, Maal T, Dieleman F, Van Cann E, Merkx M. 2010. Cone-beam CT in the assessment of mandibular invasion by oral squamous cell carcinoma: Results of the preliminary study. Int J Oral Maxillofac Surg 39(5):436–439.
19. 18F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC. Clin Oral Investig 18(3):969–978.
20. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. 2008. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14(19):6246–6252.
21. Hung P-S, Liu C-J, Chou C-S, Kao S-Y, Yang C-C, Chang K-W, Chiu T-H, Lin S-C. 2013. MiR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS ONE 8(11):e79926.
22. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, Wang A, Dai Y, Zhou X. 2010. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432(1):199–207.
23. Jiang W-W, Masayesva B, Zahurak M, Carvalho AL, Rosenbaum E, Mambo E, Zhou S, Minhas K, Benoit N, Westra WH. 2005. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 11(7):2486–2491.
24. Jin Y, Wang C, Liu X, Mu W, Chen Z, Yu D, Wang A, Dai Y, Zhou X. 2011. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem 286(46):40104–40109.
25. John MAS, Li Y, Zhou X, Denny P, Ho C-M, Montemagno C, Shi W, Qi F, Wu B, Sinha U. 2004. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(8):929–935.
26. Kah JCY, Kho KW, Lee CGL, Richard CJ. 2007. Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomed 2(4):785.
27. Kai Y, Peng W, Ling W, Jiebing H, Zhuan B. 2014. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. Biochem Biophys Res Commun 448(3):308–314.
28. Kalmar JR. 2006. Advances in the detection and diagnosis of oral precancerous and cancerous lesions. Oral Maxillofac Surg Clin North Am 18(4):465–482.
29. Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, Saito M, Otsuki N, Nibu K-I, Sugimura K. 2013. Value of retrospective image fusion of 18 F-FDG PET and MRI for preoperative staging of head and neck cancer: Comparison with PET/CT and contrast-enhanced neck MRI. Eur J Radiol 82(11):2005–2010.
30. Katakura A, Kamiyama I, Takano N, Shibahara T, Muramatsu T, Ishihara K, Takagi R, Shouno T. 2007. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll 48(4):199–203.
31. Kim M, Higuchi T, Arisaka Y, Achmad A, Tokue A, Tominaga H, Miyashita G, Miyazaki H, Negishi A, Yokoo S. 2013. Clinical significance of 18F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: Comparison with 18F-FDG PET/CT and MRI. Ann Nucl Med 27(5):423–430.
32. Kolk A, Schuster T, Chlebowski A, Lange P, Scheidhauer K, Kesting M, Bissinger O, Schwaiger M, Dinges J, Weitz J. 2014. Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities. Eur J Nucl Med Mol Imaging 41(7):1363–1374.
33. Krabbe C, Balink H, Roodenburg J, Dol J, de Visscher J. 2011. Performance of 18 F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx. Int J Oral Maxillofac Surg 40(11):1263–1270.
34. Krabbe CA, Dijkstra PU, Pruim J, van der Laan BF, van der Wal JE, Gravendeel JP, Roodenburg JL. 2008. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases. Oral Oncol 44(1):31–36.
35. Kumar B, Yadav A, Lang J, Teknos TN, Kumar P. 2012. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS ONE 7(5):e37601.
36. Kushraj T, Chatra L, Shenai P, Rao PK. 2011. Bone invasion in oral cancer patients: A comparison between orthopantamograph, conventional computed tomography, and single positron emission computed tomography. J Cancer Res Ther 7(4):438.
37. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 2008. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: A meta-analysis. J Natl Cancer Inst 100(10):712–720.
38. Lestón JS, Dios PD. 2010. Diagnostic clinical aids in oral cancer. Oral Oncol 46(6):418–422.
39. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT. 2006. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24(11):1754–1760.
40. Liao C-T, Wang H-M, Huang S-F, Chen I-H, Kang C-J, Lin C-Y, Fan K-H, Ng S-H, Hsueh C, Lee L-Y. 2011. PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med 52(2):180–187.
41. Liao P-H, Chang Y-C, Huang M-F, Tai K-W, Chou M-Y. 2000. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 36(3):272–276.
42. Linz C, Müller-Richter U, Buck A, Mottok A, Ritter C, Schneider P, Metzen D, Heuschmann P, Malzahn U, Kübler A. 2015. Performance of cone beam computed tomography in comparison to conventional imaging techniques for the detection of bone invasion in oral cancer. Int J Oral Maxillofac Surg 44(1):8–15.
43. Lisa Cheng Y-S, Wright J. 2011. Advances in diagnostic adjuncts for oral squamous cell carcinoma. Open Pathol J 5:3–7.
44. Liu C-J, Tsai M-M, Hung P-S, Kao S-Y, Liu T-Y, Wu K-J, Chiou S-H, Lin S-C, Chang K-W. 2010. MiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70(4):1635–1644.
45. Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, Lin SC, Chang KW. 2014. MiR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer 134(4):811–821.
46. Lu L, Xue X, Lan J, Gao Y, Xiong Z, Zhang H, Jiang W, Song W, Zhi Q. 2014. MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis. Biomed Pharmacother 68(1):13–19.
47. Min A, Zhu C, Peng S, Rajthala S, Costea DE, Sapkota D. 2015. MicroRNAs as important players and biomarkers in oral carcinogenesis. Biomed Res Int 2015:186904.
48. Mirzaei H, Fathullahzadeh S, Khanmohammadi R, Darijani M, Momeni F, Masoudifar A, Goodarzi M, Mardanshah O, Stanveng J, Jaafari MR. 2017a. State of the art in MicroRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia. J Cell Physiol. [Epub ahead of print].
49. Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jafaari MR, Mirzaei HR, Hassanian SM, Avan A. 2016a. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer 53:25–32.
50. Mirzaei H, Momeni F, Saadatpour L, Sahebkar A, Goodarzi M, Masoudifar A, Kouhpayeh S, Salehi H, Mirzaei HR, Jaafari MR. 2017b. MicroRNA: Relevance to stroke diagnosis, prognosis and therapy. J Cell Physiol. [Epub ahead of print].
51. Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, Reza Mirzaei H, Salehi H, Peyvandi M, Pawelek JM, Sahebkar A. 2016b. Curcumin: A new candidate for melanoma therapy? Int J Cancer 139(8):1683–1695.
52. Mirzaei H, Sahebkar A, Jaafari MR, Goodarzi M, Mirzaei HR. 2016c. Diagnostic and therapeutic potential of exosomes in cancer: The beginning of a new tale? J Cell Physiol. [Epub ahead of print].
53. Mirzaei H, Yazdi F, Salehi R, Mirzaei HR. 2016d. SiRNA and epigenetic aberrations in ovarian cancer. J Cancer Res Ther 12(2):498.
54. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S, Sugahara T. 1997. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res 18(6B):4645–4649.
55. Mohammadi M, Goodarzi M, Jaafari M, Mirzaei H, Mirzaei H. 2016. Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Ther 23(11):371–372.
56. Momin MA, Okochi K, Watanabe H, Imaizumi A, Omura K, Amagasa T, Okada N, Ohbayashi N, Kurabayashi T. 2009. Diagnostic accuracy of cone-beam CT in the assessment of mandibular invasion of lower gingival carcinoma: Comparison with conventional panoramic radiography. Eur J Radiol 72(1):75–81.
57. Moridikia A, Mirzaei H, Sahebkar A, Salimian J. 2017. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol. [Epub ahead of print].
58. Muto M, Ugumori T, Sano YI, Ohtsu A, Yoshida S. 2005. Narrow-band imaging combined with magnified endoscopy for cancer at the head and neck region. Dig Endosc 17(s1):S23–S24.
59. Ng S-H, Yen T-C, Chang JT-C, Chan S-C, Ko S-F, Wang H-M, Lee L-Y, Kang C-J, Wong AM-C, Liao C-T. 2006. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24(27):4371–4376.
60. Olivo M, Bhuvaneswari R, Keogh I. 2011. Advances in bio-optical imaging for the diagnosis of early oral cancer. Pharmaceutics 3(3):354–378.
61. Ozer E, Naiboğlu B, Meacham R, Ryoo C, Agrawal A, Schuller DE. 2012. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol 269(11):2411–2414.
62. Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI. 2000. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696.
63. Paiva RRD, Figueiredo PTDS, Leite AF, Silva MAG, Guerra ENS. 2011. Oral cancer staging established by magnetic resonance imaging. Braz Oral Res 25(6):512–518.
64. Pandeshwar P, Jayanthi K, Raghuram P. 2013. Pre-operative contrast enhanced computer tomographic evaluation of cervical nodal metastatic disease in oral squamous cell carcinoma. Indian J Cancer 50(4):310.
65. Patton LL, Epstein JB, Kerr AR. 2008. Adjunctive techniques for oral cancer examination and lesion diagnosis: A systematic review of the literature. J Am Dent Assoc 139(7):896–905.
66. Pentenero M, Cistaro A, Brusa M, Ferraris MM, Pezzuto C, Carnino R, Colombini E, Valentini MC, Giovanella L, Spriano G. 2008. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head Neck 30(11):1488–1496.
67. Pérez MGS, Bagán JV, Jiménez Y, Margaix M, Marzal C. 2015. Utility of imaging techniques in the diagnosis of oral cancer. J Craniomaxillofac Surg 43(9):1880–1894.
68. Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, Schramm G, Popp M, Laniado M, Kotzerke J. 2014. FDG PET/MR for lymph node staging in head and neck cancer. Eur J Radiol 83(7):1163–1168.
69. Pohar S, Brown R, Newman N, Koniarczyk M, Hsu J, Feiglin D. 2007. What does PET imaging add to conventional staging of head and neck cancer patients? Int J Radiat Oncol Biol Phys 68(2):383–387.
70. Ram S, Siar C. 2005. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34(5):521–527.
71. Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A. 2013. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation implications for cancer therapeutics. J Biol Chem 288(1):608–618.
72. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R, Gilbert RW. 2010. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 9(1):1.
73. Reza Mirzaei H. 2017. Circulating microRNAs in hepatocellular carcinoma: Potential diagnostic and prognostic biomarkers. Curr Pharm Des 22(34):5257–5269.
74. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. 2005. NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29(1):42–45.
75. Roh J-L, Park JP, Kim JS, Lee JH, Cho K-J, Choi S-H, Nam SY, Kim SY. 2013. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: A prospective study. Radiology 271(1):153–161.
76. Saadatpour L, Fadaee E, Fadaei S, Mansour RN, Mohammadi M, Mousavi S, Goodarzi M, Verdi J, Mirzaei H. 2016a. Glioblastoma: Exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther 23(12):415–418.
77. Saadatpour Z, Bjorklund G, Chirumbolo S, Alimohammadi M, Ehsani H, Ebrahiminejad H, Pourghadamyari H, Baghaei B, Mirzaei H, Sahebkar A. 2016b. Molecular imaging and cancer gene therapy. Cancer Gene Ther. https://doi.org/10.1038/cgt.2016.62
78. Saadatpour Z, Rezaei A, Ebrahimnejad H, Baghaei B, Bjorklund G, Chartrand M, Sahebkar A, Morovati H, Mirzaei H, Mirzaei H. 2016c. Imaging techniques: New avenues in cancer gene and cell therapy. Cancer Gene Ther 24(1):1–5.
79. Salarini R, Sahebkar A, Mirzaei H, Jaafari M, Riahi M, Hadjati J, Asrami M, Fdaee S, Salehi R, Mirzaei H. 2015. Epi-drugs and Epi-miRs: Moving beyond current cancer therapies. Curr Cancer Drug Targets 16(9):773–788.
80. Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, Bisdas S. 2009. 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: Comparison with MR imaging and validation with surgical specimen. Neuroradiology 51(10):677–686.
81. Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, Uzawa K, Ito H, Takiguchi Y, Tanzawa H. 2013. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer 108(9):1817–1821.
82. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. 2007. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 133(9):613–617.
83. Shum JW, Dierks EJ. 2014. Evaluation and staging of the neck in patients with malignant disease. Oral Maxillofac Surg Clin North Am 26(2):209–221.
84. Siegel RL, Miller KD, Jemal A. 2016. Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30.
85. Simonian M, Mosallayi M, Mirzaei H. 2016. Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker. J Cancer Res Ther. [Epub ahead of print].
86. Thomsen J, Sørensen J, Grupe P, Karstoft J, Krogdahl A. 2005. Staging N0 oral cancer: Lymphoscintigraphy and conventional imaging. Acta Radiol 46(5):492–496.
87. Thong PS-P, Olivo M, Kho K-W, Zheng W, Mancer K, Harris M, Soo K-C. 2007. Laser confocal endomicroscopy as a novel technique for fluorescence diagnostic imaging of the oral cavity. J Biomed Optics 12(1):014007–014008.
88. Uribe S, Rojas L, Rosas C. 2013. Accuracy of imaging methods for detection of bone tissue invasion in patients with oral squamous cell carcinoma. Dentomaxillofac Radiol 42(6):20120346.
89. Vidiri A, Ruscito P, Pichi B, Pellini R, Covello R, Sperduti I, Di Giovanni S, Spriano G, Crecco M. 2007. Oral cavity and base of the tongue tumors. Correlation between clinical, MRI and pathological staging of primary tumor. J Exp Clin Cancer Res 26(4):575.
90. Wiener E, Pautke C, Link TM, Neff A, Kolk A. 2006. Comparison of 16-slice MSCT and MRI in the assessment of squamous cell carcinoma of the oral cavity. Eur J Radiol 58(1):113–118.
91. Yamazaki Y, Saitoh M, Notani K-I, Tei K, Totsuka Y, Takinami S-I, Kanegae K, Inubushi M, Tamaki N, Kitagawa Y. 2008. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 22(3):177–184.
92. Yen Y-C, Shiah S-G, Chu H-C, Hsu Y-M, Hsiao J-R, Chang J-Y, Hung W-C, Liao C-T, Cheng A-J, Lu Y-C. 2014. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer 13(1):1.
93. Yoon DY, Hwang HS, Chang SK, Rho Y-S, Ahn HY, Kim JH, Lee IJ. 2009. CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19(3):634–642.
94. Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z. 2014. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 33(42):5017–5027.